COVID-19. Coronavirus infection, unspecified
Conditions
Interventions
Intervention 1: Intervention group: patients will receive standard treatments and inflawell syrup (Provided by KondorPharma Co, Canada) containing standardized Boswellic acids powder 3 times a day 10
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: COVID-19 patient admitted to the infectious ward of the hospital Age = 18 years in both sexes Confirmation of SARS-CoV2 infection based on PCR test and clinical manifestations including: 1. Respiratory distress (breathing = 25 times per minute) or 2. Percentage of oxygen saturation at rest =92% Early diagnosis (less than or equal to 8 days from the onset of symptoms) Signing the informed consent form
Exclusion criteria
Exclusion criteria: Liver, kidney and heart failure Inability of the patient to consume the oral form Pregnancy and lactation or positive pregnancy test Participate in two or more clinical trials simultaneously
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of hospital stay. Timepoint: Day 7 and 14 after the intervention. Method of measurement: Number of days. | — |
Secondary
| Measure | Time frame |
|---|---|
| C-reactive protein (CRP). Timepoint: Baseline and 14 days after intervention. Method of measurement: ELISA technique. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammadreza Salehi
Tehran University of Medical Sciences
Outcome results
None listed